Sandoz Confirms Launch Of Humira Rival In Canada

Introduction Of Hyrimoz Comes As Other Adalimumab Biosimilars Expected

 
• By David Wallace
  
Canada Flag Rocket Clouds Launch
Sandoz has confirmed launch of its adalimumab biosimilar in Canada • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products